Comparison of serum and salivary ghrelin in healthy adults, morbidly obese, and patients with metastatic carcinoma.
BACKGROUND
Ghrelin, a known orexigenic hormone, has been demonstrated to be produced and released by salivary glands. Obtaining saliva for metabolism studies would be preferable for patients since the procedure is non-invasive.


METHODS
The present study examined serum and salivary ghrelin levels in 41 morbidly obese subjects, 45 healthy controls, and 17 patients with metastatic carcinoma by using a commercial radioimmunoassay.


RESULTS
When comparing serum and salivary levels under fasting conditions, ghrelin levels were significantly higher in saliva for morbidly obese and healthy subjects. A significant correlation between salivary and serum ghrelin could only be demonstrated for healthy subjects. Fasting serum ghrelin concentrations in morbidly obese patients were significantly lower compared with healthy controls and cancer patients, however the levels in whole saliva did not differ significantly between all groups. There was only a highly significant inverse correlation between BMI and serum ghrelin. Serum ghrelin correlated positively with age in morbidly obese. There was no significant difference in serum and saliva ghrelin concentrations between men and women. Following the standardized meal, no significant suppression of serum ghrelin levels in morbidly obese was observed, however salivary ghrelin concentrations were significantly decreased.


CONCLUSIONS
The results of the present study support the hypothesis that there is an autonomous production of ghrelin in the salivary glands. Further research should focus on factors involved in the regulation of salivary ghrelin. Until the mechanism of regulation is fully understood, the testing of ghrelin levels in saliva is too limited to recommend a switch from serum testing.
Benedix
Frank
F
Department of General, Visceral and Vascular Surgery, Otto-von-Guericke, University Magdeburg, Magdeburg, Germany. frankbenedix@gmx.de
Westphal
Sabine
S
Patschke
Robert
R
Luley
Claus
C
Lippert
Hans
H
Wolff
Stephanie
S
D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000097:blood / Q000378:metabolism; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000097:blood / Q000378:metabolism* / Q000473:pathology; D054439:Ghrelin / Q000032:analysis / Q000097:blood / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009767:Obesity, Morbid / Q000097:blood / Q000378:metabolism*; D012463:Saliva / Q000378:metabolism*
D015415:Biomarkers; D054439:Ghrelin
J Surg Res. 2007 Jul;141(1):31-9
17574036
Br J Nutr. 2005 Jun;93(6):765-71
16022744
Peptides. 2006 Apr;27(4):878-82
16191452
Peptides. 2005 Apr;26(4):647-52
15752580
J Clin Endocrinol Metab. 2005 Feb;90(2):1068-71
15522935
J Clin Endocrinol Metab. 2005 May;90(5):2920-6
15713718
Diabetes. 2001 Apr;50(4):707-9
11289032
Diabetes. 2001 Aug;50(8):1714-9
11473029
Clin Chem. 2005 Jun;51(6):997-1006
15790755
J Clin Endocrinol Metab. 2007 Oct;92(10):3935-40
17652221
J Clin Endocrinol Metab. 2001 Oct;86(10):4753-8
11600536
Zentralbl Chir. 2009 Feb;134(1):24-31
19242879
J Am Soc Nephrol. 2002 Nov;13(11):2748-52
12397045
BMB Rep. 2008 Jan 31;41(1):55-61
18304451
Appetite. 2009 Feb;52(1):104-7
18831996
Nature. 1999 Dec 9;402(6762):656-60
10604470
Am J Clin Nutr. 2008 Jan;87(1):12-22
18175732
Obes Res. 2004 Jul;12(7):1108-16
15292475
Clin Cancer Res. 2003 Feb;9(2):774-8
12576449
Mol Cell Biochem. 2009 Aug;328(1-2):49-56
19262995
J Clin Endocrinol Metab. 2003 Dec;88(12):5747-52
14671163
J Endocrinol. 2002 Oct;175(1):R1-5
12379512
Obes Surg. 2008 Nov;18(11):1424-9
18542849
J Biochem Mol Biol. 2007 Jan 31;40(1):29-35
17244479
Gut. 2006 Mar;55(3):433-4
16474111
Z Gerontol Geriatr. 2007 Feb;40(1):31-6
17318729
Zentralbl Chir. 2009 Feb;134(1):32-7
19242880
J Int Med Res. 2009 May-Jun;37(3):757-65
19589259
J Clin Endocrinol Metab. 2002 Jun;87(6):2984
12050284
J Clin Endocrinol Metab. 2004 Apr;89(4):1630-5
15070922
J Clin Endocrinol Metab. 2004 May;89(5):2136-41
15126531